ASCO 2026 wasn’t just about new data—it highlighted where oncology is headed next. From breakthrough in vivo CAR-T results and RAS-targeted therapies to the growing influence of Chinese biotech on the global stage, this year’s meeting showcased the evolving future of cancer care. Listen to the recap: https://www.fiercepharma.com/pharma/behind-headlines-asco-2026
More Tips From The Bandish Group
How AI Is Changing the Career Plans of Students and Young Professionals
◆
Artificial intelligence is influencing more than how people work—it is also changing how students think about their education and future…
Retained Executive Search for Smarter Leadership Hiring
◆
Finding the right executive takes more than reviewing resumes or scheduling interviews. Senior leaders shape strategy, influence culture, and guide…